@article{article, title = {{Additional efficacy and safety outcomes and an exploratory analysis of the impact of pathological complete response (pCR) on long-term outcomes from NIAGARA.}},
publisher = {{American Society of Clinical Oncology (ASCO)}},
url = {{https://doi.org/10.1200/jco.2025.43.5_suppl.659 }},
year = {{2025}},
month = {{2}},
author = {{Galsky MD and Van Der Heijden MS and Catto JWF and Al-Ahmadie H and Meeks JJ and Nishiyama H and Drakaki A and Vu TQ and Antonuzzo L and Atduev V and Kann AG et al}},
doi = {{10.1200/jco.2025.43.5_suppl.659}},
volume = {{43}},
journal = {{Journal of Clinical Oncology}},
issue = {{5_suppl}},
pages = {{659-659}},
note = {{Accessed on 2025/07/16}}}